Lv1
10 积分 2024-08-18 加入
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
7个月前
已完结
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-labeled, randomised, long-term extension trials
8个月前
已完结
皖公网安备34019202002308
